PTAB Again Denies Review Of Merck Anti-Nausea Drug
The Patent Trial and Appeal Board on Tuesday refused a request from Apotex Inc. to reconsider its decision not to review Merck Sharp & Dohme Corp.'s patent for Emend, an anti-nausea...To view the full article, register now.
Already a subscriber? Click here to view full article